BR0212502A - Uso de lh em hiperestimulação ovariana controlada - Google Patents

Uso de lh em hiperestimulação ovariana controlada

Info

Publication number
BR0212502A
BR0212502A BR0212502-1A BR0212502A BR0212502A BR 0212502 A BR0212502 A BR 0212502A BR 0212502 A BR0212502 A BR 0212502A BR 0212502 A BR0212502 A BR 0212502A
Authority
BR
Brazil
Prior art keywords
ovarian hyperstimulation
controlled ovarian
coh
day
controlled
Prior art date
Application number
BR0212502-1A
Other languages
English (en)
Inventor
Stephen Hillier
Colin Michael Howles
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0212502(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0212502A publication Critical patent/BR0212502A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"USO DE LH EM HIPERESTIMULAçãO OVARIANA CONTROLADA". A invenção refere-se a um novo uso de LH, e análogos tendo atividade de LH, para auxiliar na foliculogênese em hiperestimulação ovariana controlada (COH), onde o LH ou um seu análogo é administrado durante um período de preparação que dura do dia 1 até por volta do dia 4 da fase de estimulação em COH.
BR0212502-1A 2001-09-12 2002-09-12 Uso de lh em hiperestimulação ovariana controlada BR0212502A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
BR0212502A true BR0212502A (pt) 2004-08-24

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212502-1A BR0212502A (pt) 2001-09-12 2002-09-12 Uso de lh em hiperestimulação ovariana controlada

Country Status (28)

Country Link
US (1) US7341989B2 (pt)
EP (1) EP1434600B1 (pt)
JP (1) JP2005504072A (pt)
KR (1) KR20040032953A (pt)
CN (1) CN1302806C (pt)
AR (1) AR036591A1 (pt)
AT (1) ATE427755T1 (pt)
AU (1) AU2002331939B2 (pt)
BR (1) BR0212502A (pt)
CA (1) CA2457067A1 (pt)
CY (1) CY1110487T1 (pt)
DE (1) DE60231892D1 (pt)
DK (1) DK1434600T3 (pt)
EA (1) EA009210B1 (pt)
ES (1) ES2322136T3 (pt)
HK (1) HK1067866A1 (pt)
HR (1) HRP20040070A2 (pt)
IL (1) IL160781A0 (pt)
ME (1) MEP38808A (pt)
MX (1) MXPA04002125A (pt)
NO (1) NO327154B1 (pt)
PL (1) PL205472B1 (pt)
PT (1) PT1434600E (pt)
RS (1) RS51505B (pt)
SI (1) SI1434600T1 (pt)
UA (1) UA78970C2 (pt)
WO (1) WO2003022301A2 (pt)
ZA (1) ZA200401008B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL373991A1 (en) * 2002-06-07 2005-09-19 Ares Trading S.A. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
ES2267531T5 (es) * 1999-05-07 2015-11-24 Merck Serono Sa Uso de LH administrada en la fase folicular media o tardía para el tratamiento de mujeres anovulatorias

Also Published As

Publication number Publication date
UA78970C2 (uk) 2007-05-10
RS51505B (sr) 2011-06-30
ZA200401008B (en) 2005-08-31
ATE427755T1 (de) 2009-04-15
HK1067866A1 (en) 2005-04-22
DK1434600T3 (da) 2009-05-25
CY1110487T1 (el) 2015-04-29
CN1302806C (zh) 2007-03-07
DE60231892D1 (de) 2009-05-20
PL367343A1 (en) 2005-02-21
NO20040990L (no) 2004-03-08
YU21204A (sh) 2006-08-17
EA009210B1 (ru) 2007-12-28
NO327154B1 (no) 2009-05-04
MXPA04002125A (es) 2004-07-08
KR20040032953A (ko) 2004-04-17
IL160781A0 (en) 2004-08-31
CN1553809A (zh) 2004-12-08
AU2002331939B2 (en) 2007-10-25
EP1434600B1 (en) 2009-04-08
WO2003022301A2 (en) 2003-03-20
JP2005504072A (ja) 2005-02-10
EP1434600A2 (en) 2004-07-07
ES2322136T3 (es) 2009-06-17
WO2003022301A3 (en) 2003-04-17
US7341989B2 (en) 2008-03-11
MEP38808A (en) 2011-02-10
US20050049199A1 (en) 2005-03-03
EA200400428A1 (ru) 2004-08-26
AR036591A1 (es) 2004-09-22
PL205472B1 (pl) 2010-04-30
PT1434600E (pt) 2009-04-28
SI1434600T1 (sl) 2009-06-30
CA2457067A1 (en) 2003-03-20
HRP20040070A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
IT1284758B1 (it) Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
HUP0003349A2 (hu) Mellékpajzsmirigy-hormon peptidanalógok, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
BR9106702A (pt) Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
FR2623082B1 (fr) Cheville artificielle par la fixation intra-osseuse de prothese et renforts ligamentaires, ainsi que l'impacteur associe comportant des moyens de maintien de ladite cheville
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
BR0212502A (pt) Uso de lh em hiperestimulação ovariana controlada
DE69814394D1 (de) Verwendung von levobupivacain
ATE192037T1 (de) Verwendung von arginin als immunstimulator
BR0212429A (pt) Uso de hcg na hiperestimulação ovariana controlada
ES2177849T3 (es) Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
IT1317927B1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
AU2251302A (en) Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
ES2183534T3 (es) Agentes cosmeticos o farmaceutios que contienen acidos ribonucleicos o acidos desoxirribonucleicos.
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE112169T1 (de) Menschliche myeloperoxidase und therapeutische verwendung.
KR930021178A (ko) 뼈 형성을 자극하는 약제
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
DE69626312D1 (de) Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
ATE433749T1 (de) Neue verwendung von rapamycin und strukturellen analoga hiervon

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B25D Requested change of name of applicant approved

Owner name: MERCK SERONO S.A. (CH)